๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cytokine profile defines different responses to interferon-alpha treatment in chronic hepatitis C virus infection

โœ Scribed by Antonietta Giannattasio; Munter Hussain; Giorgina Mieli-Vergani; Raffaele Iorio; Angela Vegnente; Diego Vergani


Book ID
119228331
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
55 KB
Volume
38
Category
Article
ISSN
1590-8658

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Serum hepatitis C virus (HCV)-RNA and re
โœ Dr. S. Magrin; A. Craxi; C. Fabiano; G. Fiorentino; L. Marino; P. Almasio; G. B. ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 731 KB

## Abstract Hepatitis C virus (HCV) replication was assessed before and during alphaโ€interferon (IFN) treatment in 22 antiโ€HCV positive patients with posttransfusion or sporadic chronic hepatitis (CH). Eleven patients were โ€œrespondersโ€ and 11 patients โ€œnonโ€respondersโ€ to IFN. Thirteen antiโ€HCV nega

Variants in interferon-alpha pathway gen
โœ Tania Mara Welzel; Timothy R. Morgan; Herbert L. Bonkovsky; Deepa Naishadham; Ru ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 270 KB ๐Ÿ‘ 2 views

Combination treatment with pegylated-interferon-alpha (PEG IFN-โฃ) and ribavirin, the current recommended therapy for chronic hepatitis C virus (HCV) infection, results in a sustained virological response (SVR) in only about half of patients. Because genes involved in the interferon-alpha pathway may